Error: Could not add to watchlist. X
+ Watchlist

Recro Pharma Inc

REPH:US
NASDAQ CM
7.03
USD
0.07
0.99%
As of 10:38 AM EDT 6/26/2017
Open
7.10
Day Range
6.94 - 7.12
Volume
26,537
Previous Close
7.10
52Wk Range
5.81 - 12.50
1 Yr Return
-11.01%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
7.10
Day Range
6.94 - 7.12
Volume
26,537
Previous Close
7.10
52Wk Range
5.81 - 12.50
1 Yr Return
-11.01%
YTD Return
-12.78%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-1.99
Market Cap (m USD)
133.001
Shares Outstanding (m)
19.055
Price/Sales (TTM)
1.24
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.11%
% Price Change
-0.06%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Recro Pharma, Inc. is a specialty pharmaceutical company. The Company develops non-opioid therapeutics for the treatment of pain in the post-operative setting. Recro Pharma offers its products to the medical industry.
Address
490 Lapp Road
Malvern, PA 19355
United States
Phone
1-484-395-2400
  • Geraldine A Henwood "Gerri"
    President/CEO
  • Michael Celano
    Chief Financial Officer
  • Frederick H Graff
    Chief Commercial Officer
  • Stewart McCallum
    Chief Medical Officer
  • Ryan D Lake
    Senior VP:Finance/Chief Acctg Ofcr
Show More